title: Enhanced connexin-43 and alpha-sarcomeric actin expression in cultured heart myocytes exposed to triiodo-L-thyronine.
abstract: This study examined whether triiodo-L-thyronine (T3) affects the expression of the major intercellular channel protein, connexin-43, and contractile protein alpha-sarcomeric actin. Cultured cardiomyocytes from newborn rats were treated on day three in culture with 10 or 100 nM T3 and examined 48 and 72 h thereafter. Treated and untreated cells were examined by immunofluorescence and electron microscopy. Expression levels of Cx43 and sarcomeric alpha-actin were monitored by Western blot analysis. Immunofluorescence labeling showed cell membrane location of Cx43 in punctuate gap junctions, whereby fluorescence signal area was significantly higher in cultured cardiomyocytes exposed to T3. This correlated with electron microscopical findings showing increased numbers and size of gap junction profiles, as well as with a significant dose-dependent increase of Cx43 expression detected by Western blot. Immunofluorescence of sarcomeric a-actin was enhanced and its expression increased dose- and time-dependently in T3-treated cultured heart myocytes. However, exposure to the higher dosage (100 nM) of T3 caused mild disintegration of sarcomeric a-actin in some myocytes, suggesting an over-dosage. The results indicate that T3 up-regulates Cx43 and accelerates gap junction formation in cultured neonatal cardiomyocytes. They suggest that thyroid status cannot only modulate the mechanical function of cardiomyocytes but also cell-to-cell communication essential for myocardial electrical and metabolic synchronizations.
authors.affiliation: Institute for Heart Research, SAS, Bratislava, Slovak Republic.
authors.forename: Narcis
authors.initials: N
authors.lastname: Tribulova
authors.forename: Vladimir
authors.initials: V
authors.lastname: Shneyvays
authors.forename: Liaman K
authors.initials: LK
authors.lastname: Mamedova
authors.forename: Shay
authors.initials: S
authors.lastname: Moshel
authors.forename: Tova
authors.initials: T
authors.lastname: Zinman
authors.forename: Asher
authors.initials: A
authors.lastname: Shainberg
authors.forename: Mordechai
authors.initials: M
authors.lastname: Manoach
authors.forename: Peter
authors.initials: P
authors.lastname: Weismann
authors.forename: Sawa
authors.initials: S
authors.lastname: Kostin
mesh_terms: D000199:Actins / Q000096:biosynthesis* / Q000235:genetics; D000818:Animals; D002478:Cells, Cultured; D018031:Connexin 43 / Q000096:biosynthesis* / Q000235:genetics; D004305:Dose-Response Relationship, Drug; D005786:Gene Expression Regulation / Q000187:drug effects*; D032383:Myocytes, Cardiac / Q000378:metabolism* / Q000648:ultrastructure; D051381:Rats; D014284:Triiodothyronine / Q000494:pharmacology*
chemical_list: D000199:Actins; D018031:Connexin 43; D014284:Triiodothyronine